Evaluating Biophoton Therapy's Effect on Stem Cell Growth
A Randomized Double Blinded and Placebo-Controlled Trial to Assess the Impact of Biophoton Therapy on Self-Grown Stem Cells
This study is testing if a special light therapy can help people grow more of their own stem cells and reduce inflammation.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 46 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | First Institute of All Medicines Academic / other |
| Locations | 2 sites (Tampa, Florida and 1 other locations) |
| Trial ID | NCT06855459 on ClinicalTrials.gov |
What this trial studies
This clinical study aims to assess the effectiveness of biophoton therapy using Tesla BioHealing® Biophoton Generators in increasing self-grown stem cells. It is designed as a randomized, double-blinded, placebo-controlled intervention involving approximately 46 volunteers. Participants will be assigned to either a treatment group receiving biophoton therapy or a control group using placebo devices for a duration of 2 weeks. The study will monitor changes in stem cell levels and inflammation as primary outcomes.
Who should consider this trial
Good fit: Ideal candidates are healthy adults aged 18-70 who are interested in increasing their stem cell levels and meet the study's eligibility criteria.
Not a fit: Patients with untreated psychiatric disturbances or those who have recently undergone stem cell therapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this therapy could enhance the natural production of stem cells, potentially improving regenerative health.
How similar studies have performed: While biophoton therapy is a novel approach, similar studies exploring non-invasive methods to enhance stem cell production have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Willing and able to give informed consent for participation in the trial. * Is able and willing to comply with all trial requirements. * Male or female ages 18-70 years old without major diseases. * Participants must not be heavy users of Tesla BioHealing devices; enrollment will be determined by the clinical team based on an evaluation of the participant's prior device usage. * Must be fluent in English. Exclusion Criteria: * Untreated psychiatric disturbances that would affect trial participation as judged by the research medical professional. * Is participating in another investigational drug or device trial * Had been treated with Stem Cell therapy within a 6-month period.
Where this trial is running
Tampa, Florida and 1 other locations
- Tesla MedBed at Tampa-FL — Tampa, Florida, United States (Recruiting)
- Tesla BioHealing Wellness Hotel - Butler-PA — Butler, Pennsylvania, United States (Recruiting)
Study contacts
- Study coordinator: Mariola Smotrys, MD, MBA, MSc
- Email: Mariola.Smotrys@firstallmed.org
- Phone: (302) 500-3010
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.